Henry Schein, Inc.

HSIC · NasdaqGS · Stock · Healthcare
$84.76
-0.32% today
Delayed price,

What Henry Schein does

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Key facts

Sector
Healthcare
Industry
Medical Distribution
Market cap
$9.45B
P/E (ttm)
24.7
Forward P/E
14.1
Dividend yield
0.00%
Beta
0.84
Profit margin
3.0%
Employees
25,000
Headquarters
Melville, NY, United States
Exchange
NasdaqGS

Performance

1 Month
-0.1%
3 Months
-3.5%
6 Months
+7.5%
1 Year
+34.6%
5 Years
+19.3%
$61.9552-week range$92.18
Biggest setback — last 12 months
-14.0%
23 Feb 2026 → 4 May 2026
Fell from $82.39 to $70.82 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+42.6%
13 Oct 2025 → 31 Aug 2026
Ran from $62.98 to $89.81 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$79.51 (-6.2%)$84.76$90.36 (+6.6%)
3 Months$75.87 (-10.5%)$84.76$94.70 (+11.7%)
6 Months$72.46 (-14.5%)$84.76$99.15 (+17.0%)
12 Months$67.91 (-19.9%)$84.76$105.80 (+24.8%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 22.2%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Sold 4,587 shares at $88.86 — Albertini Andrea, CEO, Global Dist. & Tech. · 2026-09-09
Acquired 2,215 shares — DANIEL WILLIAM K, Director · 2026-06-15
Sold 50 shares — BERGMAN STANLEY M, Director · 2026-05-22
Sold 1,040 shares — BERGMAN STANLEY M, Director · 2026-05-21
Acquired 10,000 shares at $69.19 — DANIEL WILLIAM K, Director · 2026-05-12
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.